Effect of Intervention for Colonoscopy Quality is Associated With the Personal Characteristics

NCT03796169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-09-09

No results posted yet for this study

Summary

This study aims to investigate whether the personal characteristics of the endoscopist is associated with effect of interventions for colonoscopy quality improvement.

This is a prospective, 9-month, multicenter, single-blind study. Baseline quality indicators including adenoma detection rate, polyp detection rate, withdrawal time and adenomas per colonoscopy of each endoscopist were measured in the health promotion centers of academic hospitals for 3 months. Follow-up measurements of quality indicators were repeated every 3 months after each interventions (personal notification of quality indicators, open notification of quality indicators, and colonoscopy quality education by a GI faculty. At the end of the study, personal characteristics of each endoscopist was evaluated using fear of negative evaluation scale, cognitive flexibility inventory, and almost perfect scale.

Conditions

  • Colonoscopy
  • Human Characteristics

Interventions

BEHAVIORAL

Personal notification

Baseline quality indicators of each endoscopist were measured and those were notified individually.

BEHAVIORAL

Open notification

Quality indicators were measured for 3 months after 1st interventions and those were notified openly

BEHAVIORAL

Education

Quality indicators were measured for 3 months after 2nd interventions and educated the importance of colonoscopy quality by a GI faculty

Sponsors & Collaborators

  • Saint Vincent's Hospital, Korea

    collaborator OTHER
  • Uijeongbu St. Mary Hospital

    collaborator OTHER
  • Seoul St. Mary's Hospital

    lead OTHER

Principal Investigators

  • Bo-In Lee, MD, PhD · Division of Gastroenterology; Seoul St. Mary's hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2019-12-12
Completion
2020-02-12

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796169 on ClinicalTrials.gov